Washington, DC (December 4, 2025) The American Pharmacists Association (APhA) is deeply disappointed by today’s vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to remove the universal recommendation for administering the hepatitis B vaccine birth dose for infants born in the United States. This reversal rolls back a highly effective, evidence-based public health measure that has been in place since 1991.

WASHINGTON, DC (December 1, 2025) — The American Pharmacists Association (APhA) and the American Academy of HIV Medicine (AAHIVM) today announced that AAHIVM has formally endorsed the clinical and educational content of APhA’s Pharmacy-Based HIV Prevention Services Certificate Training Program and Microcredential.

Washington, DC (October 31, 2025) — The American Pharmacists Association (APhA) has joined the American Association of Colleges of Pharmacy (AACP) as a program partner in the Unite for Impact Challenge, a national initiative designed to spark collaboration, innovation, and measurable change in community pharmacy practice.